Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Current Opinion in Nephrology and Hypertension|June 6, 2017
Do effects of sodium-glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease?Harindra Rajasekeran, David Z Cherney, Julie A LovshinKidney International|February 17, 2016
Sodium-glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresisHarindra Rajasekeran, Yuliya Lytvyn, David Z I CherneyAmerican Journal of Physiology. Renal Physiology|April 7, 2017
Urinary adenosine excretion in type 1 diabetesHarindra Rajasekeran, Yuliya Lytvyn, Andrea Bozovic, et al.Diabetes Care|May 28, 2017
Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α<sup>1-67</sup> in Patients With Type 2 DiabetesJulie A Lovshin, Harindra Rajasekeran, Yulyia Lytvyn, et al.American Journal of Physiology. Renal Physiology|November 17, 2017
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot studyHarindra Rajasekeran, Heather N Reich, Michelle A Hladunewich, et al.Pageof 1